Literature DB >> 21666150

A world without measles.

Peter M Strebel1, Stephen L Cochi, Edward Hoekstra, Paul A Rota, David Featherstone, William J Bellini, Samuel L Katz.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21666150     DOI： 10.1093/infdis/jir111

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  33 in total

1.  Enhancing the work of the Department of Health and Human Services national vaccine program in global immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on September 12, 2013.

Authors: 
Journal:  Public Health Rep       Date:  2014       Impact factor: 2.792

2.  Rapid Identification of Measles Virus Vaccine Genotype by Real-Time PCR.

Authors:  Felicia Roy; Lillian Mendoza; Joanne Hiebert; Rebecca J McNall; Bettina Bankamp; Sarah Connolly; Amy Lüdde; Nicole Friedrich; Annette Mankertz; Paul A Rota; Alberto Severini
Journal:  J Clin Microbiol       Date:  2016-11-16       Impact factor: 5.948

3.  A microneedle patch containing measles vaccine is immunogenic in non-human primates.

Authors:  Chris Edens; Marcus L Collins; James L Goodson; Paul A Rota; Mark R Prausnitz
Journal:  Vaccine       Date:  2015-03-12       Impact factor: 3.641

4.  Measles vaccination using a microneedle patch.

Authors:  Chris Edens; Marcus L Collins; Jessica Ayers; Paul A Rota; Mark R Prausnitz
Journal:  Vaccine       Date:  2012-10-05       Impact factor: 3.641

5.  Functional and structural characterization of neutralizing epitopes of measles virus hemagglutinin protein.

Authors:  Maino Tahara; Yuri Ito; Melinda A Brindley; Xuemin Ma; Jilan He; Songtao Xu; Hideo Fukuhara; Kouji Sakai; Katsuhiro Komase; Paul A Rota; Richard K Plemper; Katsumi Maenaka; Makoto Takeda
Journal:  J Virol       Date:  2012-10-31       Impact factor: 5.103

6.  Nonfebrile seizures after mumps, measles, rubella, and varicella-zoster virus combination vaccination with detection of measles virus RNA in serum, throat, and urine.

Authors:  Isabella Eckerle; Brigitte Keller-Stanislawski; Sabine Santibanez; Stephan Buderus; Matthias Hillmann; Christian Drosten; Anna Maria Eis-Hübinger
Journal:  Clin Vaccine Immunol       Date:  2013-05-01

Review 7.  Synergizing vaccinations with therapeutics for measles eradication.

Authors:  Richard K Plemper; Anthea L Hammond
Journal:  Expert Opin Drug Discov       Date:  2013-12-05       Impact factor: 6.098

8.  Accelerating measles and rubella elimination through research and innovation - Findings from the Measles & Rubella Initiative research prioritization process, 2016.

Authors:  Gavin B Grant; Balcha G Masresha; William J Moss; Mick N Mulders; Paul A Rota; Saad B Omer; Abigail Shefer; Jennifer L Kriss; Matt Hanson; David N Durrheim; Robert Linkins; James L Goodson
Journal:  Vaccine       Date:  2019-03-20       Impact factor: 3.641

9.  Age-appropriate vaccination against measles and DPT-3 in India - closing the gaps.

Authors:  Niyi Awofeso; Anu Rammohan; Kazi Iqbal
Journal:  BMC Public Health       Date:  2013-04-17       Impact factor: 3.295

10.  Experimental adaptation of wild-type canine distemper virus (CDV) to the human entry receptor CD150.

Authors:  Maria Bieringer; Jung Woo Han; Sabine Kendl; Mojtaba Khosravi; Philippe Plattet; Jürgen Schneider-Schaulies
Journal:  PLoS One       Date:  2013-03-12       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.